Since it was founded Advicenne has acquired real pediatric expertise with a view to registering drugs destined for children.
Commitment to pediatric patients
For ethical reasons all our clinical developments seek to minimize the number of children exposed, the period of exposure to the drug under investigation, and invasive procedures such as taking blood samples.
- We use new statistical tools, approaches of meta-analysis and data modeling/simulation in order to be able to extrapolate the efficacy and safety of use data in the target population from data obtained from adults or groups of children of a different age.
- We consider that the recruitment of specially qualified and motivated investigators is a key point in the success of our developments.
- We put in place highly qualified medical, scientific, technical and regulatory personnel to monitor the correct conduct of our trials.
- All our trials comply with European Good Clinical Practices.